fda glp-1 warning letters september 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading FDA warns Novo Nordisk of

Eat more fiber Dietary fiber, especially soluble fiber found in fruits, vegetables, legumes, and whole grains, promotes the release of GLP-1

doi: 10.1177/1535370215576313 [DOI] [PMC free article] [PubMed] [Google Scholar] 113.Imamura K, Hishikawa N, Sawada M, et al

Clinical Evidence for Tirzepatide Weight Loss Effectiveness The SURMOUNT trials demonstrated that tirzepatide produced weight reductions of 2122% of baseline body weight at maximum dose over 68 weeks, significantly outperforming semaglutide alone (16%) and placebo (23%)

commercial plans still do not cover Wegovy, Zepbound, or other GLP-1s for weight loss as of 2026 coverage is more common for type 2 diabetes (Ozempic, Mounjaro) than for obesity

As part of ongoing patient assessment, healthcare providers should also ensure their patient is being treated with the optimum dose that achieves the best balance between efficacy, tolerability and acceptability [125]